send to a friend by email

Jerusalem Pharmaceuticals earns a pretax income of JD2.78 million in the year of 2011

2012-02-16

The Palestine Exchange (PEX) received consolidated unaudited year-end preliminary financial statements from Jerusalem Pharmaceuticals Company ( JPH). The PEX disclosure rules in place give all of PEX listed companies a period of 45 days to report their preliminary annual financial statements reviewed by the company’s internal auditor. This disclosure was published on the PEX website (www.pex.ps) and emailed to PEX member securities firms in addition to this press release.

The disclosed information includes:          

1) A copy of the year-end preliminary financial statements signed by the Chairman, General Manager, and CFO of the company. The disclosed information includes: The Balance Sheet, the Income Statement, Changes in Equity Ownership, the Statement of Cash Flows. Notes to the financial statements were not included.

2) The company attached with the disclosure “the summary of year-end preliminary financial statements” form for PEX, and it include: basic information about the company, the date for the convening of the annual ordinary General Assembly meeting, the date of publication of the annual report, the distribution plan for the annual report, in addition to a summary of preliminary results for the year 2011 compared with the audited results of 2010.

3) The company also provided its interim financial statements via the approved electronic form of disclosure applicable to the Industry Sector.

4) copy of this disclosure was sent to the Palestinian Capital Market Authority (PCMA) simultaneously.

According to company data for year-end preliminary financial statements for year 2011, net profit before taxes reached 2,779,087 JOD, compared with a net profit before taxes of 2,627,575 JOD in the audited data for 2010, a net increase of 5.8%. Total assets of the company reached 33,791,478 JOD as of December 31st, 2011, compared to total assets of 28,745,051 JOD as of December 31^st, 2010, a net increase of 17.6%. Total liabilities of the company reached 9,314,559 JOD as of December 31st, 2011, compared to total liabilities of 6,187,869 JOD as of December 31^st, 2010, a net increase of 50.5%. Net ownership equity of the company reached 24,476,920 JOD (including 265,398 JOD in Minority Rights) as of December 31st, 2011, compared with a net ownership equity of 22,557,182 JOD (including 76,538 JOD in Minority Rights) as of December 31^st, 2010, a net increase of 8.5%.